EGFR L858R

Clinical trials for EGFR L858R explained in plain language.

Never miss a new study

Get alerted when new EGFR L858R trials appear

Sign up with your email to follow new studies for EGFR L858R, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

CRISPR gene editing tested as last hope for tough lung cancers

Disease control Not yet recruiting

This early-stage study is testing a new gene-editing treatment called EDB-102 for people with advanced lung cancer that has spread to the liver and stopped responding to standard drugs. The treatment uses CRISPR technology, delivered directly to the liver, to try to disable a spe…

Matched conditions: EGFR L858R

Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

EGFR L858R

Get alerted when new EGFR L858R trials appear

CRISPR gene editing tested as last hope for tough lung cancers